Skip to content

Contact +44 (0) 20 7060 7474 email us

Pipeline

Prostate Cancer Drug Pipeline Report

 

Publication Date February 2008
Publisher Life Science Analytics
Product Type
Pages 30
ISBN Number not applicable
Product Code LSA03120

Price

£985.00
approximately: $1,491 | €1,099

pdf

Buy Now

print £1,545 ($2,339 | €1,724)

Buy Now

Order above formats by FAX

Order by Fax

Summary

Life Science Analytics', "Prostate Cancer Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of prostate cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

  • Each Life Science Analytics' Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
  • In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

  • Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
  • Keep track of your competitors and partners by better understanding their product pipeline.
  • Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
  • Maintain a critical competitive advantage.

Contents

  • Recent Highlights and Changes
    • Recent Highlights and Changes
  • Upcoming Patent Expires by Therapy Area
  • Prostate Cancer Pipeline Overview
    • % of Projects (by Phase of Development)
    • No. of Projects by Phase of Development
    • Marketed Products vs. Pipeline Products
  • Company Overview - Pipeline Projects
    • Company Overview - Pipeline Projects
    • Legend
    • Top 20 companies in late stage Prostate Cancer Projects
    • Top 20 companies in early stage Prostate Cancer Projects
  • Full Pipeline View
    • Pre Clinical Pipeline View
    • Phase I Pipeline View
    • Phase II Pipeline View
    • Phase III Pipeline View